97 related articles for article (PubMed ID: 20643449)
1. Participation of older patients with prostate cancer in Medicare eligible trials.
Craig BM; Gilbert SM; Herndon JB; Vogel B; Quinn GP
J Urol; 2010 Sep; 184(3):901-6. PubMed ID: 20643449
[TBL] [Abstract][Full Text] [Related]
2. Patient income level and cancer clinical trial participation.
Unger JM; Hershman DL; Albain KS; Moinpour CM; Petersen JA; Burg K; Crowley JJ
J Clin Oncol; 2013 Feb; 31(5):536-42. PubMed ID: 23295802
[TBL] [Abstract][Full Text] [Related]
3. Disparity in Clinical Trial Participation Among Patients with Gastrointestinal Cancer.
Abbas A; Diaz A; Obeng-Gyasi S; Cloyd JM; Ejaz A; Stewart JH; Pawlik TM
J Am Coll Surg; 2022 Apr; 234(4):589-598. PubMed ID: 35290279
[TBL] [Abstract][Full Text] [Related]
4. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor.
Sadetsky N; Lubeck DP; Pasta DJ; Latini DM; DuChane J; Carroll PR
BJU Int; 2008 Mar; 101(6):691-7. PubMed ID: 18291018
[TBL] [Abstract][Full Text] [Related]
5. Total Medicare Costs Associated With Diagnosis and Treatment of Prostate Cancer in Elderly Men.
Trogdon JG; Falchook AD; Basak R; Carpenter WR; Chen RC
JAMA Oncol; 2019 Jan; 5(1):60-66. PubMed ID: 30242397
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.
Sadetsky N; Elkin EP; Latini DM; DuChane J; Carroll PR;
Prostate Cancer Prostatic Dis; 2008; 11(3):280-7. PubMed ID: 17893700
[TBL] [Abstract][Full Text] [Related]
7. Enrollment of older persons in cancer trials after the medicare reimbursement policy change.
Gross CP; Wong N; Dubin JA; Mayne ST; Krumholz HM
Arch Intern Med; 2005 Jul; 165(13):1514-20. PubMed ID: 16009867
[TBL] [Abstract][Full Text] [Related]
8. Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER-Medicare investigation.
Beebe-Dimmer JL; Ruterbusch JJ; Cooney KA; Bolton A; Schwartz K; Schwartz AG; Heath E
Cancer Med; 2019 Jun; 8(6):3325-3335. PubMed ID: 31094098
[TBL] [Abstract][Full Text] [Related]
9. Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.
Harlan SR; Cooperberg MR; Elkin E; Lubeck DP; Meng M; Mehta SS; Carroll PR
J Urol; 2003 Nov; 170(5):1804-7. PubMed ID: 14532780
[TBL] [Abstract][Full Text] [Related]
10. Variation in use of active surveillance among men undergoing expectant treatment for early stage prostate cancer.
Filson CP; Schroeck FR; Ye Z; Wei JT; Hollenbeck BK; Miller DC
J Urol; 2014 Jul; 192(1):75-80. PubMed ID: 24518783
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Medicare Low-income Subsidy on Access to Treatment, Treatment Choice, and Oncologic Outcomes in Patients With Metastatic Prostate Cancer.
Joyce DD; Qin X; Sharma V; Boorjian SA; Barocas DA; Dusetzina SB; Moses KA
J Urol; 2023 Sep; 210(3):447-453. PubMed ID: 37341420
[TBL] [Abstract][Full Text] [Related]
12. The population level prevalence and correlates of appropriate and inappropriate imaging to stage incident prostate cancer in the medicare population.
Makarov DV; Desai RA; Yu JB; Sharma R; Abraham N; Albertsen PC; Penson DF; Gross CP
J Urol; 2012 Jan; 187(1):97-102. PubMed ID: 22088337
[TBL] [Abstract][Full Text] [Related]
13. Fifteen-year Outcomes Following Conservative Management Among Men Aged 65 Years or Older with Localized Prostate Cancer.
Lu-Yao GL; Albertsen PC; Moore DF; Lin Y; DiPaola RS; Yao SL
Eur Urol; 2015 Nov; 68(5):805-11. PubMed ID: 25800944
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic Cancer Clinical Treatment Trials Accrual: A Closer Look at Participation Rates.
Guerra CE; Kelly S; Redlinger C; Hernández P; Glanz K
Am J Clin Oncol; 2021 Jun; 44(6):227-231. PubMed ID: 33710138
[TBL] [Abstract][Full Text] [Related]
15. Association of functional status and treatment choice among older men with prostate cancer in the Medicare Advantage population.
Jacobs BL; Lopa SH; Yabes JG; Nelson JB; Barnato AE; Degenholtz HB
Cancer; 2016 Oct; 122(20):3199-3206. PubMed ID: 27379732
[TBL] [Abstract][Full Text] [Related]
16. Addressing multilevel barriers to clinical trial participation among Black and White men with prostate cancer through the PACCT study.
Eggly S; Senft N; Kim S; Heath EI; Jang H; Moore TF; Baidoun F; Manning MA; Penner LA; Albrecht TL; Carducci MA; Lansey D; Hamel LM
Cancer Med; 2023 Apr; 12(7):8604-8613. PubMed ID: 36540051
[TBL] [Abstract][Full Text] [Related]
17. Early effect of Medicare Shared Savings Program accountable care organization participation on prostate cancer care.
Borza T; Kaufman SR; Yan P; Herrel LA; Luckenbaugh AN; Miller DC; Skolarus TA; Jacobs BL; Hollingsworth JM; Norton EC; Shahinian VB; Hollenbeck BK
Cancer; 2018 Feb; 124(3):563-570. PubMed ID: 29053177
[TBL] [Abstract][Full Text] [Related]
18. Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials.
Unger JM; Coltman CA; Crowley JJ; Hutchins LF; Martino S; Livingston RB; Macdonald JS; Blanke CD; Gandara DR; Crawford ED; Albain KS
J Clin Oncol; 2006 Jan; 24(1):141-4. PubMed ID: 16330670
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric Magnetic Resonance Imaging Is Associated with Increased Medicare Spending in Prostate Cancer Active Surveillance.
Macleod LC; Yabes JG; Fam MM; Bandari J; Yu M; Maganty A; Furlan A; Filson CP; Davies BJ; Jacobs BL
Eur Urol Focus; 2020 Mar; 6(2):242-248. PubMed ID: 31031042
[TBL] [Abstract][Full Text] [Related]
20. Hospice use among Medicare managed care and fee-for-service patients dying with cancer.
McCarthy EP; Burns RB; Ngo-Metzger Q; Davis RB; Phillips RS
JAMA; 2003 May; 289(17):2238-45. PubMed ID: 12734135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
